Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseases

Rebecca Ferrisi(University of Pisa), Francesca Gado(University of Pisa), Costanza Ceni(European Theoretical Spectroscopy Facility), Marco Macchia(University of Pisa), Clementina Manera(University of Pisa), Simone Bertini(University of Pisa)

Pharmacological Research

June 2, 2021

10.1016/j.phrs.2021.105607

Cited by 20

Related Papers

Hybrid lipid-AuNP clusters as highly efficient SERS substrates for biomedical applications

|Nature Communications|2024|57

Machine Learning-Based Virtual Screening for the Identification of Cdk5 Inhibitors

|International Journal of Molecular Sciences|2022|33

Antioxidant-Conjugated 1,2,4-Triazolo[4,3-<i>a</i>]pyrazin-3-one Derivatives: Highly Potent and Selective Human A<sub>2A</sub> Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain

|Journal of Medicinal Chemistry|2019|21

Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist

|Life|2020|20

Discovery of first-in-class multi-target adenosine A2A receptor antagonists-carbonic anhydrase IX and XII inhibitors. 8-Amino-6-aryl-2-phenyl-1,2,4-triazolo [4,3-a]pyrazin-3-one derivatives as new potential antitumor agents

|European Journal of Medicinal Chemistry|2020|11